Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05690971 · ClinicalTrials.gov registry record · NA
Psychosocial Mobile App for Chronic Graft-Versus-Host Disease
A NA study of Chronic Graft Versus Host Disease and Allogeneic Stem Cell Transplant, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05690971 is a NA study of Chronic Graft Versus Host Disease and Allogeneic Stem Cell Transplant that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 120 participants, roughly in line with the 112-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05690971, a NA study of Chronic Graft Versus Host Disease and Allogeneic Stem Cell Transplant, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life, symptom burden, psychological distress, and coping in patients living with chronic graft-versus host disease (GVHD)
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL App
Study Locations (1)
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-01-23 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05690971
The ClinicalTrials.gov registry entry for NCT05690971 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 112-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Graft Versus Host Disease appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05690971 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05690971 about?
NCT05690971 is a clinical study titled "Psychosocial Mobile App for Chronic Graft-Versus-Host Disease". The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life, symptom burden, psychological distress, and coping in patients living with chronic graft-versus host disease (GVHD)
What is the current status of trial NCT05690971?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-01-23. Estimated completion is 2026-06-01.
What conditions does trial NCT05690971 study?
This clinical trial studies the following conditions: Chronic Graft Versus Host Disease, Allogeneic Stem Cell Transplant.
What interventions are being tested in trial NCT05690971?
The interventions under investigation include: Usual Care (BEHAVIORAL), App (BEHAVIORAL).
Who is sponsoring clinical trial NCT05690971?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05690971 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Graft Versus Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
RECRUITING · NA
-
Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease
ACTIVE NOT RECRUITING · NA
-
Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease
ACTIVE NOT RECRUITING · NA
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
A Long-term Extension Study of PCI-32765 (Ibrutinib)
RECRUITING · Phase 3
-
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
RECRUITING
Explore more on PlainTrial
Chronic Graft Versus Host Disease
All registered trials for this condition
Allogeneic Stem Cell Transplant
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.